Prosidion Ltd. Report issue

For profit Phase 2
Founded: Oxford United Kingdom (2002)
Status: Defunct (2012)

Organization Overview

First Clinical Trial
2011
NCT01386099
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now